The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate.

Area of Science:

• Pediatric Medicine
• Neuroscience
• Public Health

Background:

• Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder associated with increased risks.
• Injuries represent a significant public health concern, particularly in pediatric populations.
• The potential impact of ADHD on injury risk and the role of pharmacological interventions require thorough investigation.

Purpose of the Study:

• To investigate the association between ADHD and the incidence of traumatic injuries in adolescents and young adults.
• To determine if methylphenidate (MPH) treatment mitigates the elevated injury risk in children diagnosed with ADHD.

Main Methods:

• A retrospective cohort study utilized electronic health records from Maccabi Healthcare Services.
• The study included adolescents aged 12-20 newly diagnosed with ADHD and a matched control group.
• Cox proportional hazard regression and nested case-control analyses were employed to assess injury risk and MPH's effect.

Main Results:

• The ADHD cohort exhibited a 63% higher incidence of traumatic injuries compared to controls (aHR=1.63).
• A significantly increased risk was observed for severe injuries (aHR=1.72).
• Methylphenidate (MPH) use was linked to a 28% reduction in injury events, with medium- or long-acting formulations showing greater efficacy.

Conclusions:

• Children and adolescents with ADHD have a substantially elevated risk of experiencing injuries.
• Methylphenidate (MPH) treatment demonstrates a significant protective effect, reducing injury risk.
• Injury prevention should be a key consideration in the comprehensive clinical management of ADHD, balancing risks and benefits beyond academic outcomes.